Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia

Subjects

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Patient overall survival (OS) and GVHD-free, failure-free survival (GFFS) as assessed using Kaplan−Meier analysis.

References

  1. 1.

    Bacigalupo A. Alternative donor transplants for severe aplastic anemia. Hematol Am Soc Hematol Educ Progr. 2018;1:467–73.

  2. 2.

    Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, et al. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. Lancet Oncol. 2016;17:164–73.

  3. 3.

    Christopeit M, Schutte V, Theurich S, Weber T, Grothe W, Behre G. Rituximab reduces the incidence of acute graft-versus-host disease. Blood. 2009;113:3130–1.

  4. 4.

    Liu L, Liu S, Zhang Y, Zhou H, Wang Q, Tian H, et al. Excellent outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria: a single-center study. Biol Blood Marrow Transpl. 2019;25:1544–9.

  5. 5.

    Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25.

  6. 6.

    Sarantopoulos S, Blazar BR, Cutler C, Ritz JB. Cells in chronic graft versus host disease. Biol Blood Marrow Transpl. 2015;21:16–23.

  7. 7.

    Focosi D, Zucca A, Scatena F. The role of anti-HLA antibodies in hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2011;17:1585–8.

  8. 8.

    Pan Z, Yuan X, Li Y, Wu X, Zhu W, Bao X, et al. Dynamic detection of antieHuman leukocyte antigen (HLA) antibodies but not HLA-DP loci mismatches can predict acute graft-versus-host disease and overall survival in HLA 12/12 matched unrelated donor allogeneic hematopoietic stem cell transplantation for hematological malignancies. Biol Blood Marrow Transpl. 2016;22:86–95.

  9. 9.

    Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M, et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol. 2016;175:265–74.

Download references

Acknowledgements

This work was partly supported by grants from National Key R&D Program of China (2016YFC0902800, 2017YFA0104502, 2017ZX09304021), Innovation Capability Development Project of Jiangsu Province (BM2015004), Jiangsu Provincial Key Medical Center (YXZXA2016002), Jiangsu Medical Outstanding Talents Project (JCRCA2016002) and Priority Academic Program Development of Jiangsu Higher Education Institutions.

Author information

Correspondence to Miao Miao or Depei Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, L., Zhang, Y., Liu, S. et al. Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-0788-6

Download citation